Approval · Notice of Compliance 20854 · 2018
ALPHANATE: Notice of Compliance 20854
Issued May 11, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20854
- Date
- May 11, 2018
- Company
- Grifols Biologicals LlcLos Angeles, California, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- ANTIHEMOPHILIC FACTOR (HUMAN) 250 UNIT per VIAL
- VON WILLEBRAND FACTOR (HUMAN) 300 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (HUMAN) 500 UNIT per VIAL
- VON WILLEBRAND FACTOR (HUMAN) 600 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (HUMAN) 1,000 UNIT per VIAL
- VON WILLEBRAND FACTOR (HUMAN) 1,200 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (HUMAN) 1,500 UNIT per VIAL
- VON WILLEBRAND FACTOR (HUMAN) 1,800 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (HUMAN) 2,000 UNIT per VIAL
- VON WILLEBRAND FACTOR (HUMAN) 2,400 UNIT per VIAL